During generalized immune complex-induced inflammation of the peritoneal cavity, two peaks of tumor necrosis factor (TNF) were observed in the peritoneal exudate of normal mice. In mast cell-deficient mice, the first peak was undetected, and the second peak of TNF and neutrophil influx were significantly reduced. Antibody to TNF significantly inhibited neutrophil infiltration in normal but not in mast cell-deficient mice. Mast cell repletion of the latter normalized TNF, neutrophil mobilization, and the effect of the antibody to TNF. Thus, in vivo, mast cells produce the TNF that augments neutrophil emigration.
The strategic location of mast cells at the host-environment interface and their ability to release potent mediators of inflammation have suggested that these cells may play a pivotal role in host defense against bacterial infection. The ability of the opportunistic pathogen, Escherichia coli, to induce degranulation of mast cells obtained from the mouse peritoneum was investigated. We determined that unlike a mutant derivative deficient in the FimH subunit of the fimbriae or nonfimbriated E. coli, type 1 fimbriated E. coli induced mast cell degranulation in vitro. The magnitude of mast cell degranulation was directly proportional to the number of adherent bacteria on the cell surface in the initial period of the interaction. Using a mouse model of bacterial peritonitis, we demonstrated mast cell degranulation and histamine release by type 1 fimbriated bacteria in vivo. Furthermore, beads coated with FimH but not with FimA, the major subunit of type 1 fimbriae, evoked mast cell release of histamine in vivo in amounts comparable to that elicited by type 1 fimbriated E. coli. These studies reveal that mast cells can be degranulated by interaction with type 1 fimbriated E. coli and that FimH, the mannose-binding component of the fimbriae, is a potent mast cell stimulant. (J. Clin. Invest. 1994.
Immune complex-induced injury is an important pathogenic factor in antibody-mediated nephritis, systemic lupus erythematosus, rheumatoid arthritis, and other diseases. In
The release of slow reacting substance (SRS) from rat basophilic leukemia cells (RBL-1) by the ionophore A23187 (5-10 Ag/ml) was stimulated 5-fold by arachidonate and inhibited 78% by 5,8,11,14-eicosatetraynoate (an inhibitor of both fatty acid cyclooxygenase and lipoxygenase). Linoleic acid and linolenic acid both inhibited SRS formation, whereas indomethacin (a cyclooxygenase inhibitor) had no effect. Radiolabel from ["4C-or [3H]arachidonate was incorporated into SRS as indicated by comigration of radioactivity and bioreactivity in several chromatographic systems after purification to apparent radiochemical homogeneity. The radiolabeled SRS was clearly separated chromatographically from other known arachidonate metabolites. Thus, SRS appears to be a previously undescribed product of arachidonic acid metabolism, probably formed through the lipoxygenase pathway. The ability to prepare purified, biosyntletically labeled, SRS should be of considerable help in further studies of its structure, biologic function, and catabolism. Slow reacting substance (SRS) is a polar acidic lipid (or group of related lipids) of unknown structure with potent contractile activity for bronchial and ileal smooth muscle. It is readily distinguished from prostaglandins (PGs), thromboxane A2, and other agents known to contract smooth muscle by its spectrum of muscle activity (1), inhibition by the specific SRS antagonist FPL 55712 (2), and various chromatographic and physicochemical criteria (3,4). SRS is formed and released from lung, leukocytes, and other tissues during IgE-mediated allergic reactions as well as in response to a variety of nonimmunologic stimuli, the most potent of which is the calcium ionophore A23187 (1,(5)(6)(7)(8)(9). We have recently demonstrated that a line of rat basophilic leukemia cells (RBL-1) (10) with receptors for IgE (11) releases considerable quantities of SRS upon stimulation with A23187 (12, 13). The SRS from RBL-1 cells is very similar or identical in its biological and chromatographic properties to previously described SRSs from various cat, rat, or human tissues (12). With the availability of a cell line that makes large amounts of SRS, studies of SRS structure and biosynthesis should be considerably facilitated. Because SRS is an acidic lipid, and metabolites of arachidonic acid (AA) have recently been recognized as showing a wide range of biological and biochemical properties (reviewed in ref. 14), we have studied the possible role of AA in SRS formation in RBL-1 cells. Strong evidence implicating AA as a biosynthetic precursor of SRS will be described. (Sigma). A23187 was dissolved in dimethylsulfoxide and diluted with incubation medium (see below) immediately before addition to cells. Over the concentration range present in our incubation mixtures dimethylsulfoxide itself had no effect on SRS formation. None of the reagents used in this study, including AA, had significant effects in our standard guinea pig ileal bioassay system. MATERIALS AND METHODSRBL-1 cells were grown in Eagle's m...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.